ALR Insider Trading Activity and SEC Form 4 Filings
ALR insider trading summary
No open-market insider purchases or sales of AlerisLife Inc. (ALR) have been reported on SEC Form 4 in the past 12 months.
Latest ALR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 18, 2023 | Adam D. Portnoy | Insider | Buy | $29.3M (22,375,687 @ $1.31) |
| Feb 1, 2016 | Melissa Guerdan | SVP, Global Quality & Reg. | Sell | $135K (2,500 @ $54.00) |
| Nov 13, 2015 | Robert Bernard Hargadon | SVP, Global Human Resources | Buy | $39K (1,000 @ $38.99) |
| Nov 12, 2015 | James F. Hinrichs | Executive VP, CFO | Buy | $400K (10,000 @ $39.97) |
| Sep 3, 2015 | Melissa Guerdan | SVP, Global Quality & Reg. | Sell | $267K (5,135 @ $52.00) |
| Sep 3, 2015 | Mark Gladwell | Senior VP, Global Operations | Sell | $139K (2,651 @ $52.27) |
| Sep 1, 2015 | Melissa Guerdan | SVP, Global Quality & Reg. | Sell | $252K (5,000 @ $50.48) |
| Aug 31, 2015 | Mark Gladwell | Senior VP, Global Operations | Sell | $1.4M (27,513 @ $52.23) |
| Aug 14, 2015 | Sanjay Malkani | Global Pres., Toxicology | Sell | $1.7M (31,460 @ $54.60) |
| Aug 7, 2015 | James F. Hinrichs | Executive VP, CFO | Buy | $987K (20,000 @ $49.33) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.